5-Chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole

Catalog No. :
ACROSB674
CAS No. :
887623-87-2
Molecular Formula :
C8H4Cl2N2S
Molecular Weight :
231.11

IUPAC Name:5-chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole

5-Chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$71.00Login to see priceIn stockInquiry
250mg95%$122.00Login to see priceIn stockInquiry
1g95%$296.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole
IUPAC Name5-chloro-3-(4-chlorophenyl)-1,2,4-thiadiazole
MDL No.MFCD14707344
Molecular FormulaC8H4Cl2N2S
Molecular Weight231.11
SMILESClC1=CC=C(C2=NSC(Cl)=N2)C=C1
InChI KeyMZLWEBFWFODGTC-UHFFFAOYSA-N
Synonym5-CHLORO-3-(4-CHLOROPHENYL)-1,2,4-THIADIAZOLE;3-(4-chlorophenyl)-5-chloro-1,2,4-thiadiazole;1,2,4-Thiadiazole, 5-chloro-3-(4-chlorophenyl)-
CAS No.887623-87-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACROSB674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACESVR048 route compound structure diagram
    ACESVR04814401-51-5 In Stock
  4. Then
  5. ACROSB674 route product structure diagram
    ACROSB674887623-87-2 In Stock
Inquiry

2. ACROSB674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPSBA043 route compound structure diagram
    ACPSBA0432254-88-8 In Stock
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1 In Stock
  4. Then
  5. ACROSB674 route product structure diagram
    ACROSB674887623-87-2 In Stock
Inquiry

Comments (0)